Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|July 2, 2024
A method for rapid and reliable quantification of VEGF-cell binding activityPrabuddha Waduge, Avinash Kaur, Wei Li
Methods (San Diego, Calif.)|November 5, 2018
Chemical probing for examining the structure of modified RNAs and ligand binding to RNAPrabuddha Waduge, Yogo Sakakibara, Christine S Chow
Drug Discovery Today|November 7, 2022
Profiling disease-selective drug targets: From proteomics to ligandomicsPrabuddha Waduge, Hong Tian, Keith A Webster, et al.
Biomolecules|January 25, 2025
Feasibility of Ex Vivo LigandomicsPrabuddha Waduge, Remya Ammassam Veettil, Bojun Zhang, et al.
Biomedicines|July 29, 2023
Anti-Scg3 Gene Therapy to Treat Choroidal Neovascularization in MiceChengchi Huang, Liyang Ji, Avinash Kaur, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 17, 2021
Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularizationLiyang Ji, Prabuddha Waduge, Lili Hao, et al.
International Journal of Molecular Sciences|September 14, 2024
Optimal Humanized Scg3-Neutralizing Antibodies for Anti-Angiogenic Therapy of Diabetic RetinopathyChengchi Huang, Prabuddha Waduge, Avinash Kaur, et al.
Cellular and Molecular Life Sciences : CMLS|January 10, 2022
Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathyChang Dai, Prabuddha Waduge, Liyang Ji, et al.
Pageof 2